轉移是腫瘤細胞從原先位置轉移至其他器官,因此能發展出具有良好的抗轉移抑制劑,進而抑制腫瘤細胞從原先位置轉移至其他器官,是我們實驗室致力合成的目標。 本文所合成之isomalyngamide A 類似物,主要是以天然物isomalyngamide A結構做改變。我們以不同linkers及醣類化合物,合成出一系列的化合物,期望能找出其活性與結構間的關係。 將所合成之化合物作生物活性測試,以isomalyngamide 類似物4的活性結果為基準,利用MDA-MB-231 乳癌細胞進行細胞傷口癒合測試,發現AE-98、AE-105及AE-107具有抗轉移的潛力。
Metastasis is a combination of multiple biological events that results in migration of cancer cells from primary sites to secondary organs. Therefore, purposes and objectives of this study are making effort to develop effective anti-migration inhibitors and perhaps inhibit migration of cancer cells from primary sites to secondary organs in animal model in the near future. In the thesis, we initially synthesized potential anti-migration inhibitors of the isomalyngamide A analogs. Then we used different linkers and sugars to design and prepare a series of compounds which are needed to evaluate their biological activities and strcture-activity relationship (SAR). In wound healing assay, we found that compounds AE-98, AE-105, AE-107 possess potent anti-metastasis ability in comparison with the isomalyngamide analog 4, an anti-migration inhibitor.